FDA NDC Directory · JSON-LD · Markdown

IMKELDI

NDC 81927-201 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nameimatinib oral
Labeler / ManufacturerShorla Oncology Inc.,
Marketing categoryNew Drug Application (innovator) · App NDA219097
Dosage form / routeSOLUTION · ORAL
Active ingredientsIMATINIB MESYLATE (80 mg/mL)
Marketing started20241219
Package count1

External sources

Source: openFDA. Public-domain (CC0).